Bookmarks
ISARIC4C COVID-19 Clinical Information Network (CO-CIN)
Population Size
270,230
People
Years
2020
Associated BioSamples
Faeces
Plasma
...see more
Geographic coverage
United Kingdom
Lead time
2-4 weeks
Summary
ISARIC4C (Coronavirus Clinical Characterisation Consortium) has collected the following data and samples from: 270,230 patients at Tier Zero case report forms (CO-CIN) - data only 2,510 patients at Tier 1/2 (host/viral multiomics) - samples
Documentation
Dataset type
Dataset sub-type
Dataset population size
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
|---|---|---|---|---|
Persons | 270230 | Count | 20 Nov 2020 |
Provenance
Purpose of dataset collection
Source of data extraction
Collection source setting
Patient pathway description
Image contrast
Biological sample availability
Structural Metadata
Details
Publishing frequency
Version
Modified
08/10/2024
Citation Requirements
Coverage
Start date
30/03/2020
Time lag
Geographic coverage
Maximum age range
Follow-up
Accessibility
Language
Controlled vocabulary
Format
Data Access Request
Dataset pipeline status
Access rights
Time to dataset access
Access request cost
Access method category
Access service description
Access to all data and samples collected by ISARIC4C are controlled by an Independent Data and Materials Access Committee (IDAMAC), composed of representatives of research funders, academia, clinical medicine, public health and industry. Their job is to ensure that all data and samples are used to generate the greatest possible benefit to humanity, in the shortest possible time.
If you are interested in requesting samples or data please briefly answer the questions below and send to isaric4c-samples@roslin.ed.ac.uk, including this statement in your email:
“I agree for the contents of my application to be shared publicly on the internet and other media by the ISARIC 4C consortium.”
What samples (type & volume) or data do you need? What will you do with the samples or data ? What is your previous track record of delivering similar work? When will you complete the proposed work? How will you fund the proposed work? How do you plan to share data, results, and products from these samples? Why will this help the global response to COVID19? What assurance can you give with regards to your safe handling and secure storage of samples and data?
Jurisdiction
Data use limitation
Data use requirements
Data Controller
Data Processor